Topical anesthetic

Results: 29



#Item
21N.M. BtAle Co., lat. K093584/Amcndment I ,  510(k) Surmm.ary

N.M. BtAle Co., lat. K093584/Amcndment I , 510(k) Surmm.ary

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-04-25 00:29:20
22The Institute for Safe Medication Practices Canada (ISMP Canada) is an independent national nonprofit agency established for the collection and analysis of medication error reports and the development of recommendations

The Institute for Safe Medication Practices Canada (ISMP Canada) is an independent national nonprofit agency established for the collection and analysis of medication error reports and the development of recommendations

Add to Reading List

Source URL: www.ismp-canada.org

Language: English - Date: 2009-08-07 11:27:39
23451172A/Revised: February[removed]% Xylocaine®-MPF (lidocaine HCl) Sterile Solution Rx only DESCRIPTION: 4% Xylocaine-MPF (lidocaine HCl) Sterile Solution (Methylparaben Free) contains a

451172A/Revised: February[removed]% Xylocaine®-MPF (lidocaine HCl) Sterile Solution Rx only DESCRIPTION: 4% Xylocaine-MPF (lidocaine HCl) Sterile Solution (Methylparaben Free) contains a

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-02-25 09:04:33
24CCAC species-specific recommendations on: AMPHIBIANS AND REPTILES 1. General Considerations

CCAC species-specific recommendations on: AMPHIBIANS AND REPTILES 1. General Considerations

Add to Reading List

Source URL: www.ccac.ca

Language: English - Date: 2012-10-24 09:36:03
25Microsoft Word - pdl_notice_amden_ldo_avis_02_2014-eng.docx

Microsoft Word - pdl_notice_amden_ldo_avis_02_2014-eng.docx

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2014-02-18 11:09:59
26Consumer Health Information www.fda.gov/consumer Use Caution with A Over-the-Counter

Consumer Health Information www.fda.gov/consumer Use Caution with A Over-the-Counter

Add to Reading List

Source URL: www.fda.gov

Language: English
27FDA Labeling – Approval October 26, 2004 Page 1 of 14 Tradename (Lidocaine HCl 2% and Epinephrine 1:100,000 Solution for Topical Iontophoretic System) Clinical Pharmacology

FDA Labeling – Approval October 26, 2004 Page 1 of 14 Tradename (Lidocaine HCl 2% and Epinephrine 1:100,000 Solution for Topical Iontophoretic System) Clinical Pharmacology

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 15:48:59
28Treatment Guide Qutenza® is indicated for the management of neuropathic pain associated with postherpetic neuralgia. Gather These Supplies ❏❏ Cotton-tipped applicators

Treatment Guide Qutenza® is indicated for the management of neuropathic pain associated with postherpetic neuralgia. Gather These Supplies ❏❏ Cotton-tipped applicators

Add to Reading List

Source URL: www.qutenza.com

Language: English - Date: 2014-04-24 12:29:07
29

PDF Document

Add to Reading List

Source URL: bja.oxfordjournals.org

Language: English - Date: 2009-01-15 08:49:22